| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Sep'17 | Jun'17 |
|---|---|---|---|---|---|---|---|---|---|---|
Operating expenses | ||||||||||
Research and development | ||||||||||
18,285 | 16,582 | 16,067 | 14,111 | 15,098 | 11,031 | 8,706 | 7,149 | 6,401 | 5,333 | 3,758 |
General and administrative | ||||||||||
11,588 | 10,268 | 7,517 | 5,946 | 5,829 | 4,482 | 3,269 | 2,375 | 2,308 | 900 | 840 |
Total operating expenses | ||||||||||
29,873 | 26,850 | 23,584 | 20,057 | 20,927 | 15,513 | 11,975 | 9,524 | 8,709 | 6,233 | 4,598 |
Loss from operations | ||||||||||
-29,873 | -26,850 | -23,584 | -20,057 | -20,927 | -15,513 | -11,975 | -9,524 | -8,709 | -6,233 | -4,598 |
Interest income, net | ||||||||||
1,989 | 2,313 | 1,887 | 971 | 1,030 | 1,023 | 836 | 292 | 224 | -579 | -73 |
Other income (expense), net | ||||||||||
60 | -78 | -35 | 14 | -56 | -38 | -9 | -145 | 0 | -74 | -21 |
Loss before benefit from income taxes | ||||||||||
- | - | - | - | - | - | - | - | - | -6,886 | - |
Provision for (benefit from) income taxes | ||||||||||
- | - | - | - | - | - | - | - | - | -966 | - |
Net loss | ||||||||||
-27,824 | -24,615 | -21,732 | -19,072 | -19,953 | -14,528 | -11,148 | -9,377 | -8,485 | -5,920 | -4,692 |
Unrealized gain on marketable securities, net of tax | ||||||||||
1,869 | 35 | -12 | 84 | 45 | 18 | -36 | 3 | 0 | 0 | - |
Comprehensive loss | ||||||||||
-25,955 | -24,580 | -21,744 | -18,988 | -19,908 | -14,510 | -11,184 | -9,374 | -8,485 | -5,920 | -4,692 |
Net loss per common share: | ||||||||||
Basic and diluted | ||||||||||
-0.57 | -0.51 | -0.47 | -0.44 | -0.47 | 6.50 | -0.34 | -4.17 | -4.19 | -3.60 | -3.18 |
Weighted-average number of common shares outstanding: | ||||||||||
Basic and diluted | ||||||||||
48,691 | 48,749 | 46,280 | 43,115 | 42,620 | 42,451 | 32,609 | 2,248 | 2,024 | 1,643 | 1,477 |